Suchergebnisse - "Bairey, Osnat"

1

Early death in patients diagnosed with non-Hodgkin’s lymphoma

von: Bairey, Osnat

2012, in: Annals of hematology

Wird geladen...
2

The possible role of maintenance treatment for primary central nervous system lymphoma

von: Bairey, Osnat

2018, in: Blood reviews

Wird geladen...
3

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study

von: Bairey, Osnat

2011, in: Annals of hematology

Wird geladen...
4

Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities

von: Siegal, Tali

2021, in: Blood reviews

Wird geladen...
5

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes

von: Hazan-Halevy, Inbal

2015, in: GW26-e0273 Relationship between thrombelastography test and routine platelet parameters in patients with acute coronary syndrome

Wird geladen...
6

MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma

von: Shepshelovich, Daniel

2015, in: N

Wird geladen...
7

Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases

von: Shvidel, Lev

2012, in: Annals of hematology

Wird geladen...
8

Cell surface expression of CD25 antigen (surface IL-2 receptor alpha-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients

von: Shvidel, Lev

2012, in: Annals of hematology

Wird geladen...
9

Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia

von: Tadmor, Tamar

2019, in: N

Wird geladen...
10

A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

von: Habringer, Stefan

2023, in: European journal of cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!